NasdaqCM - Nasdaq Real Time Price USD

Corcept Therapeutics Incorporated (CORT)

29.28 +1.19 (+4.24%)
As of 2:54 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
523,529.00
482,375.00
401,858.00
365,978.00
353,874.00
Cost of Revenue
7,630.00
6,481.00
5,385.00
5,281.00
5,582.00
Gross Profit
515,899.00
475,894.00
396,473.00
360,697.00
348,292.00
Operating Expense
393,970.00
368,612.00
283,839.00
236,220.00
220,090.00
Operating Income
121,929.00
107,282.00
112,634.00
124,477.00
128,202.00
Net Non Operating Interest Income Expense
19,187.00
17,275.00
3,557.00
529.00
3,400.00
Pretax Income
141,116.00
124,557.00
116,191.00
125,006.00
131,602.00
Tax Provision
23,093.00
18,417.00
14,773.00
12,494.00
25,591.00
Net Income Common Stockholders
117,203.00
105,496.00
101,288.00
112,512.00
106,011.00
Diluted NI Available to Com Stockholders
117,203.00
105,496.00
101,288.00
112,512.00
106,011.00
Basic EPS
1.14
1.02
0.95
0.97
0.92
Diluted EPS
1.05
0.94
0.87
0.89
0.85
Basic Average Shares
102,286.50
103,560.00
106,787.00
115,653.00
115,412.00
Diluted Average Shares
110,364.50
111,742.00
115,966.00
125,963.00
124,194.00
Total Operating Income as Reported
121,929.00
107,282.00
112,634.00
124,477.00
128,202.00
Total Expenses
401,600.00
375,093.00
289,224.00
241,501.00
225,672.00
Net Income from Continuing & Discontinued Operation
118,023.00
106,140.00
101,418.00
112,512.00
106,011.00
Normalized Income
118,023.00
106,140.00
101,418.00
112,512.00
106,011.00
Interest Income
19,187.00
17,275.00
3,557.00
529.00
3,400.00
Net Interest Income
19,187.00
17,275.00
3,557.00
529.00
3,400.00
EBIT
121,929.00
107,282.00
112,634.00
124,477.00
128,202.00
EBITDA
123,611.00
109,644.00
116,080.00
127,953.00
130,439.00
Reconciled Cost of Revenue
7,630.00
6,481.00
5,385.00
5,281.00
5,582.00
Reconciled Depreciation
1,682.00
2,362.00
3,446.00
3,476.00
2,237.00
Net Income from Continuing Operation Net Minority Interest
118,023.00
106,140.00
101,418.00
112,512.00
106,011.00
Normalized EBITDA
123,611.00
109,644.00
116,080.00
127,953.00
130,439.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 4/14/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DYN Dyne Therapeutics, Inc.
34.54
+24.77%
 
INSM Insmed Incorporated
25.21
+1.78%
 
FOLD Amicus Therapeutics, Inc.
9.70
+1.31%
 
AKRO Akero Therapeutics, Inc.
20.21
+1.46%
 
CYTK Cytokinetics, Incorporated
60.90
+2.30%
 
COGT Cogent Biosciences, Inc.
7.72
+3.76%
 
ACLX Arcellx, Inc.
54.03
+0.76%
 
INVA Innoviva, Inc.
16.28
+1.88%
 
RVMD Revolution Medicines, Inc.
39.95
+1.37%
 
ZLAB Zai Lab Limited
20.65
+6.44%